$27.4 Million is the total value of Revelation Capital Management, LLC's 3 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS INC | $14,008,000 | -76.8% | 2,219,951 | -57.5% | 51.22% | -12.0% |
| ME | Sell | 23ANDME HOLDING CO | $10,217,000 | -67.1% | 2,667,736 | -42.8% | 37.36% | +24.6% |
| NPCE | Sell | NEUROPACE INC | $3,126,000 | -53.5% | 380,705 | -42.9% | 11.43% | +76.3% |
| CVRX | Exit | CVRX INC | $0 | – | -38,182 | -100.0% | -0.45% | – |
| NTRA | Exit | NATERA INC | $0 | – | -7,923 | -100.0% | -0.71% | – |
| Exit | SOMALOGIC INC | $0 | – | -370,839 | -100.0% | -4.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SINGULAR GENOMICS SYSTEMS INC | 4 | Q3 2022 | 83.2% |
| NEUROPACE INC | 4 | Q3 2022 | 17.4% |
| 23ANDME HOLDING CO | 2 | Q1 2022 | 37.4% |
| AKILI INC | 1 | Q3 2022 | 13.1% |
| ACCOLADE INC | 1 | Q2 2022 | 6.1% |
| SOMALOGIC INC | 1 | Q4 2021 | 4.2% |
| NATERA INC | 1 | Q4 2021 | 0.7% |
| CVRX INC | 1 | Q4 2021 | 0.4% |
View Revelation Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
View Revelation Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.